Formation Bio
Manufacturing · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
16 E 34th St Fl 10, New York City, New Y...Website
formation.bioRevenue
$41.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
3
1
1
1
1
About Formation Bio
Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.Explore more
Formation Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Formation Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Formation Bio launches new products
Formation Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Formation Bio
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Formation Bio has new funding data
Check out if Formation Bio is spiking on competitors!
Check if Formation Bio has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Formation Bio recently announced quarterly report
Click to see if Formation Bio had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Formation Bio
Find more new buyers
Compare Similar Companies to Formation Bio
Compare insights from companies similar to Formation Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$38.6M
201-500
Private
<$5M
2003
Anna FeldmanClinical Trial Support Specialist & Chief Revenue Officer, Services
Company Profile Activity
Activity Insights
Formation Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Formation Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Formation Bio.
Formation Bio financials insights
Gather financial insights about Formation Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series D
$372M
Formation Bio Tech Stack
A closer look at the technologies used by Formation Bio
Most Recent Scoops
Open Position
Open Position
Hiring Plans
Formation Bio has more open roles in Engineering & Technical than it has had at any time in the past 6 months. Technologies mentioned include: Python, dbt, Snowflake, and SQL with an increased focus that include Dagster, Software Documentation, Build Pipeline, Data Infrastructure, and Data Engineering, and experience with Data Quality, and Modularity.
Hiring Plans
Open Position
Open Position
Formation Bio News & Media
Formation Bio Doses First Participant in Phase 1 Trial of BLKR201, a CNS-Penetrant TYK2 Inhibitor
Company advances molecule from deal close to Phase 1 five months after in-licensing the asset NEW YORK, June 9, 2026 /PRNewswire/ -- Formation Bio, an AI-native pharma company, today announced dosing of the first participant in a Phase 1, first-in-human (FIH) clinical trial of BLKR201....Formation Bio Licenses miR-124 Activator for Autoimmune Diseases from CTFH
Acquisition adds a differentiated, oral, IND-stage asset with multi-indication potential to Formation Bio's rapidly growing portfolio NEW YORK, Jan. 29, 2026 /PRNewswire/ -- Formation Bio and Jiangsu Chia Tai Feng Hai Pharmaceutical Co., LTD. (CTFH) today announced Formation Bio's...Lynk Pharmaceuticals and Formation Bio Enter Exclusive Development and Licensing Agreement for LNK01006
HANGZHOU, China and SHANGHAI and BOSTON, Dec. 10, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals") and Formation Bio today announced Formation Bio's acquisition of worldwide rights, excluding Greater China, to LNK01006, a next...Lynk Pharmaceuticals and Formation Bio Enter Exclusive Development and Licensing Agreement for LNK01006
HANGZHOU, China and SHANGHAI and BOSTON, Dec. 10, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals") and Formation Bio today announced Formation Bio's acquisition of worldwide rights, excluding Greater China, to LNK01006, a next generation central nervous system (CNS)–penetrant highly selective TYK2 inhibitor. The asset will be developed within Formation Bio's newly formed subsidiary Bleecker Bio. LNK01006 recently received IND clearance from
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Formation Bio
Sign Up For FreeTo access detailed company insights
Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-sta... Read More
